US FDA's Dietary Supplement Programs Deserve A Raise, Trade Groups Tell Senate Appropriators
Compliant industry drove US market growth to $55bn in 2020, and faster growth and higher sales are ahead if FDA’s Office of Dietary Supplement Programs has sufficient funding to eliminate non-compliant businesses.
You may also be interested in...
FDA’s justification report published with Biden administration’s FY2022 federal budget request includes $1.194bn for agency’s food programs, which include its oversight of supplement industry, up from $1.11bn in FY2021 appropriation.
FDA includes cannabis product regulation in FY 2021 food safety priorities, “key areas where resources have been historically underfunded and for which there are rising public health needs as growing markets outpace increases to Agency resources,” it states in its budget request.
Without an objection from Congress, FDA’s Division of Dietary Supplement Programs becomes a CFSAN office on Dec. 21. Objections or questions from one or more members are possible, but HHS likely would not make the notification without high confidence Congress would not object.